Join the ecancer team and special guest speakers for this free educational event at the 15th St Gallen International Breast Cancer Conference in Vienna.

The event will give you an overview of how CDK 4/6 inhibitors are changing treatment plans for patients with metastatic breast cancer.

The agenda for the day is as follows:

08.00 - 08.30: Join us for a networking breakfast! Catch up with oncology colleagues and meet the symposium faculty over a hot drink and pastry.

08.30 - 10.00: Our interactive satellite symposium, chaired by Dr Giuseppe Curigliano of the European Institute of Oncology, Milan, Italy, will give you the latest emerging evidence for the optimal integration of new therapies into treatment plans.

Talk one: What are CDKs?

Get an insight into the biology of CDK 4/6 from Ghadeer Shubassi, FIRC Institute of Molecular Oncology Foundation (IFOM), Milan, Italy

Talk two: CDK inhibitors in clinical practice and under development
Pierfranco Conte, Veneto Institute of Oncology, Padova, Italy

Talk three: Clinical trial results: the benefits, side effects and costs​
Harold Burstein, Dana-Faber Cancer Institute, Boston, USA